Nuvation Bio Inc.
NUVB
$2.17
-$0.02-0.91%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -259.90% | -258.63% | -109.73% | -2,140.76% | 31.92% |
| Total Depreciation and Amortization | 434.48% | 298.18% | 194.55% | 335.71% | 3.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 107.09% | 6,615.28% | 209.94% | 16,178.29% | 37.97% |
| Change in Net Operating Assets | 159.86% | -368.15% | 171.90% | -1,458.09% | -1,441.47% |
| Cash from Operations | -171.47% | -208.08% | -92.42% | -113.46% | 18.77% |
| Capital Expenditure | -166.67% | 200.00% | -572.73% | 100.00% | -125.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 616.79% | 56.36% | 405.79% | -41.79% | 114.56% |
| Cash from Investing | 618.40% | 56.11% | 403.54% | -8.23% | 114.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5,052.38% | 865.83% | 2,068.83% | 1,430.08% | -92.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,509.52% | -850.00% | -2,097.40% | 1,966.17% | -92.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 250.56% | -68.85% | 83.45% | -101.13% | 88.54% |